Benedict Ng
University of New South Wales
7 Papers
5 Citations
Benedict Ng is an academic researcher from University of New South Wales. The author has contributed to research in topics: Gene & Lynch syndrome. The author has an hindex of 4, co-authored 7 publications.
Chat about Author
Papers
NKT and MAIT invariant TCRα sequences can be produced efficiently by VJ gene recombination
Hui Yee Greenaway,Benedict Ng,David Price,David Price,Daniel C. Douek,Miles P. Davenport,Vanessa Venturi +6 more
TL;DR: The results suggest that the immune machinery enables the canonical NKT and MAIT TCRα sequences to be produced with great efficiency through the process of convergent recombination, ensuring their prevalence across individuals and species.
66
Lynch Syndrome Associated with Two MLH1 Promoter Variants and Allelic Imbalance of MLH1 Expression
Luke B. Hesson,Deborah Packham,Chau-To Kwok,Andrea Nuñez,Benedict Ng,Christa Schmidt,Michael Fields,Jason W. H. Wong,Matthew A Sloane,Robyn L. Ward,Robyn L. Ward +10 more
TL;DR: It is proposed that the pathogenicity of previously reported variants within the MLH1 5′untranslated region (UTR) may be pathogenic due to constitutional partial loss ofMLH1 expression, and that this may be associated with intermediate penetrance of a Lynch syndrome phenotype.
34
Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors
Luke B. Hesson,Benedict Ng,Peter Zarzour,Sameer Srivastava,Sameer Srivastava,Chau To Kwok,Deborah Packham,Andrea Nuñez,Dominik Beck,Regina Ryan,Ashraf Dower,Caroline E. Ford,John E. Pimanda,Mathew A. Sloane,Nicholas J. Hawkins,Michael J. Bourke,Jason W. H. Wong,Robyn L. Ward,Robyn L. Ward +18 more
TL;DR: The finding that LSTs exhibit a mutational load similar to colorectal carcinomas has implications for the validity of molecular biomarkers for assessing cancer risk and integrated omics data identify molecular features associated with noncancerous L STs highlight that mutation load, which is relatively high in Lsts, is a poor predictor of invasive potential.
Altered promoter nucleosome positioning is an early event in gene silencing.
Luke B. Hesson,Mathew A. Sloane,Jason W. H. Wong,Andrea Nuñez,Sameer Srivastava,Benedict Ng,Nicholas J. Hawkins,Michael J. Bourke,Robyn L. Ward +8 more
TL;DR: Investigating silenced genes in adenomas suggests that silenced genes transition through an intermediary stage involving altered promoter nucleosome positioning, before permanent silencing by hypermethylation and dense nucleosomes occupancy.
25
Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial.
Lauren R. Olafson,Anna H. Siddell,Kathryn M. Field,Kathryn M. Field,Madeleine Byrnes,Robert W. Rapkins,Benedict Ng,Sheri Nixdorf,Elizabeth H Barnes,Terrance Grant Johns,Sonia Yip,John Simes,Anna K. Nowak,Mark Rosenthal,Kerrie L. McDonald +14 more
TL;DR: This biomarker sub-study attempted to identify novel biomarkers involved in cancer treatment response to bevacizumab and identified a gain in Chromosome 19 that was exclusive to the exceptional survivors.
3